High Contract Cancellations Sink Pharmaceutical Product Development
Pharmaceutical Product Development Inc. (Nasdaq: PPDI) reported higher second quarter earnings of 49 cents per share compared with 41 cents per share last year. But high contract cancellations sent the stock price plunging $3.23 to close at $18.85.
